These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20703033)
1. Antivascular endothelial growth factor for choroidal neovascularization in pathologic myopia. Battaglia Parodi M; Iacono P; Bandello F Dev Ophthalmol; 2010; 46():73-83. PubMed ID: 20703033 [TBL] [Abstract][Full Text] [Related]
3. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520 [TBL] [Abstract][Full Text] [Related]
4. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Ng DS; Kwok AK; Tong JM; Chan CW; Li WW Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Yang HS; Kim JG; Kim JT; Joe SG Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429 [TBL] [Abstract][Full Text] [Related]
7. Choroidal neovascularization in pathologic myopia. Dave V; Narayanan R Am J Ophthalmol; 2010 Nov; 150(5):752; author reply 752-3. PubMed ID: 21036211 [No Abstract] [Full Text] [Related]